Narva Apteegid OÜ

14901340

General info

Name

Narva Apteegid OÜ

Registry code

14901340

VAT number

EE102241262

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

31.01.2020 (4)

Financial year

01.01-31.12

Capital

2 500.00 €

Activity

47731 - Dispensing chemist in specialised stores

Revenue

5 196 833 €

Profit

21 884 €

Profit margin

0%

Gross salary

-

Equity

177 379 €

Employees

20

Annual report

Submitted

Tax arrears

No tax arrears

Return on equity

12%

Return on assets

2%

Related parties

Owner Representative Beneficial owner Roles

Inna Tairova

10.02.1963 (61)

100% - 2 500.00 EUR Board member Direct ownership Founder

Financial info

2020
30.06.2021
2021
30.06.2022
2022
30.06.2023
2023
30.06.2024
Total Revenue 3 140 295 € 4 575 128 € 4 871 587 € 5 196 833 €
Net profit (loss) for the period 1 525 € 86 823 € 64 647 € 21 884 €
Profit Margin 0% 2% 1% 0%
Current Assets 622 283 € 885 455 € 996 156 € 1 063 034 €
Fixed Assets - - 907 € 701 €
Total Assets 622 283 € 885 455 € 997 063 € 1 063 735 €
Current Liabilities 618 258 € 794 607 € 841 568 € 886 356 €
Non Current Liabilities - - - -
Total Liabilities - - - -
Share Capital - - - -
Equity 4 025 € 90 848 € 155 495 € 177 379 €
Employees 21 18 19 20

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 1 492 232.56 € 86 746.99 € 66 140.48 € 19
2023 Q4 1 360 975.34 € 79 846.25 € 64 975.33 € 19
2023 Q3 1 308 735.35 € 77 947.64 € 69 725.78 € 19
2023 Q2 1 331 502.29 € 80 190.25 € 67 015.03 € 22
2023 Q1 1 418 845.86 € 81 475.05 € 66 153.27 € 21
2022 Q4 1 334 349.85 € 77 001.57 € 61 253.08 € 21
2022 Q3 1 196 316.49 € 76 613.18 € 67 291.38 € 22
2022 Q2 1 236 684.41 € 72 850.79 € 59 537.65 € 22
2022 Q1 1 329 748.22 € 63 938.2 € 52 794.32 € 22
2021 Q4 1 385 539.8 € 61 939.11 € 48 705.3 € 21
2021 Q3 1 141 229.28 € 64 221.18 € 52 983.06 € 21
2021 Q2 1 099 556.58 € 59 901.16 € 51 337.18 € 20
2021 Q1 1 119 094.56 € 61 067.91 € 47 111.06 € 22
2020 Q4 1 209 582 € 65 421.21 € 49 476.91 € 21
2020 Q3 1 038 120.49 € 66 186.59 € 56 280.46 € 22
2020 Q2 616 866.32 € 25 650.33 € 18 781.04 € 22
2020 Q1 - - - 24